FWO - EP PerMed: 2nd Joint Transnational Call 2025

Research

What?

The European Partnership for Personalised Medicine (EP PerMed) aims to improve future healthcare for all citizens through personalised therapy, diagnosis and prevention.

With this call, EP PerMed will fund research projects in human health on pharmacogenomic strategies for PM approaches that address one or more of the following aspects:
• identification of new pharmacogenomic markers or signatures using (multi)-omics data in relation to drug or drug combination.
• validation of a pharmacogenomic marker or signatures using (multi)-omics data in predicting drug or drug combination outcomes.
• use pharmaco-omics strategies to determine the right dosage, the efficacy of treatments and/or the risk of adverse drug response and non-response to treatment to tailor personalised treatment pathways, including combined treatments (multi-medication).

Research projects in all disease areas are welcome. Research on polygenic drug response phenotypes is encouraged.

Exclusion: Projects focussing only on drug-drug-interaction and Projects focusing on the clinical development of new drugs.

Funding will come via FWO through the fundamental (FO) or Strategic Basic Research (SBO) channel. The type and scope of the proposed research project will determine the choice of funding channel for the research performed within Flanders (more fundamental in nature, or more aimed at economical/societal valorisation). Non-compliance with the specific requirements per funding channel might lead to non-eligibility.

The FWO can support 2 projects for a 36 months duration, with an available maximum applicable budget of 350,000 EUR (overhead included) per project/consortium.  

Who?

Projects require a truly cross-sectoral and multidisciplinary collaboration, including stakeholders from pre-clinical and clinical research, bioinformatics, Ethical, Legal and Social Aspects (ELSA) research, implementation research, health economics research, actors from the public and private sector, and end-users (or experts that can support research on the impact for end-users).
Consortia funded in this EP PerMed call are required to be interdisciplinary and trans-sectoral. Research teams forming a consortium should include investigators from a broad range of relevant scientific disciplines, research fields or sectors, and bring together the necessary expertise to achieve the objectives as well as expected impact of the research proposed.

Involving patients and citizens representatives in research projects from the onset can improve quality and relevance.

Researchers can only participate within 2 different international consortia in this call.

The PI, for each of the participating institutions applying for FWO funds, must hold an appointment that fully covers the duration of the research project.

Application?

The FWO requires pre-registration on a national/regional level as well by filling in an application form on the FWO e-portal before the deadline for submission of the pre-proposals (18 February 2025, 14:00). When you're logged on to the e-portal, you can find it under "Researcher".
It is strongly recommended to contact the FWO administration about your pre-registration at the latest one week before submission in order to verify admissibility.

For the fundamental funding channel the respective regulation applies. For the SBO channel the SBO regulation has to be taken into account: these imply projects with a primarily economic and/or societal finality, of which ‘valorisation’ is a key - and mandatory - aspect.

Given the pre-proposal already has to be OK in terms of budget, OBI has an internal deadline to check your proposal.
Internal deadline: 4 February 2025

In case the consortium includes more than one partner requesting funding from FWO, a single online form should be submitted containing all relevant information from the different Flemish partners.

around 15 May 2025: communication of the results and invitation for full proposal
Deadline submission full proposal: 17 June 2025, 14:00
Rebuttal stage: Mid/end of August 2025
Expected for October 2025: communication of the funding decisions
End of 2025, beginning of 2026: expected start of the project (subject to national procedures)

More information?

You can find more information, like the call text, the Guidelines for Applicants, the submission platform and the proposal application form on the EP PerMed partnership website.

Concerning the FWO regulations, you can consult the FWO website:
for the fundamental funding channel
for the SBO channel

The partnership EP PerMed organises a JTC2025 information day: 9 January 2025.

More information and the registration button can be found here.

Please contact research@uhasselt.be if you want to apply.

Deadline intern

04.02.2025, 18.02.2025

Contact Hasselt University?

E-mail sarah.szyr@uhasselt.be

Tel. +3211269052